208 related articles for article (PubMed ID: 22705098)
21. Identification and Validation of Radiographic Enhancement for Reliable Differentiation of CD117(+) Benign Renal Oncocytoma and Chromophobe Renal Cell Carcinoma.
Amin J; Xu B; Badkhshan S; Creighton TT; Abbotoy D; Murekeyisoni C; Attwood KM; Schwaab T; Hendler C; Petroziello M; Roche CL; Kauffman EC
Clin Cancer Res; 2018 Aug; 24(16):3898-3907. PubMed ID: 29752278
[No Abstract] [Full Text] [Related]
22. Useful markers for differential diagnosis of oncocytoma, chromophobe renal cell carcinoma and conventional renal cell carcinoma.
Geramizadeh B; Ravanshad M; Rahsaz M
Indian J Pathol Microbiol; 2008; 51(2):167-71. PubMed ID: 18603673
[TBL] [Abstract][Full Text] [Related]
23. Morphological, immunohistochemical, and chromosomal analysis of multicystic chromophobe renal cell carcinoma, an architecturally unusual challenging variant.
Foix MP; Dunatov A; Martinek P; Mundó EC; Suster S; Sperga M; Lopez JI; Ulamec M; Bulimbasic S; Montiel DP; Alaghehbandan R; Peckova K; Pivovarcikova K; Ondrej D; Rotterova P; Skenderi F; Prochazkova K; Dusek M; Hora M; Michal M; Hes O
Virchows Arch; 2016 Dec; 469(6):669-678. PubMed ID: 27631338
[TBL] [Abstract][Full Text] [Related]
24. Fine-needle aspiration biopsy of chromophobe renal cell carcinoma and oncocytoma: comparison of cytomorphologic features.
Wiatrowska BA; Zakowski MF
Cancer; 1999 Jun; 87(3):161-7. PubMed ID: 10385448
[TBL] [Abstract][Full Text] [Related]
25. HNF-1β as an immunohistochemical marker for distinguishing chromophobe renal cell carcinoma and hybrid oncocytic tumors from renal oncocytoma.
An J; Park CK; Kim M; Joo JW; Cho NH
Virchows Arch; 2021 Mar; 478(3):459-470. PubMed ID: 32816058
[TBL] [Abstract][Full Text] [Related]
26. Nuclear morphometry as a tool of limited capacity for distinguishing renal oncocytoma from chromophobe carcinoma.
Okoń K; Sińczak-Kuta A
Pol J Pathol; 2008; 59(1):9-13. PubMed ID: 18655365
[TBL] [Abstract][Full Text] [Related]
27. Decreased Mitochondrial DNA Content Drives OXPHOS Dysregulation in Chromophobe Renal Cell Carcinoma.
Xiao Y; Clima R; Busch J; Rabien A; Kilic E; Villegas SL; Timmermann B; Attimonelli M; Jung K; Meierhofer D
Cancer Res; 2020 Sep; 80(18):3830-3840. PubMed ID: 32694149
[TBL] [Abstract][Full Text] [Related]
28. Claudin-7 and claudin-8: immunohistochemical markers for the differential diagnosis of chromophobe renal cell carcinoma and renal oncocytoma.
Osunkoya AO; Cohen C; Lawson D; Picken MM; Amin MB; Young AN
Hum Pathol; 2009 Feb; 40(2):206-10. PubMed ID: 18799195
[TBL] [Abstract][Full Text] [Related]
29. Distinguishing Benign Renal Tumors with an Oncocytic Gene Expression (ONEX) Classifier.
McGillivray PD; Ueno D; Pooli A; Mendhiratta N; Syed JS; Nguyen KA; Schulam PG; Humphrey PA; Adeniran AJ; Boutros PC; Shuch B
Eur Urol; 2021 Jan; 79(1):107-111. PubMed ID: 32972793
[TBL] [Abstract][Full Text] [Related]
30. Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma.
Tan MH; Wong CF; Tan HL; Yang XJ; Ditlev J; Matsuda D; Khoo SK; Sugimura J; Fujioka T; Furge KA; Kort E; Giraud S; Ferlicot S; Vielh P; Amsellem-Ouazana D; Debré B; Flam T; Thiounn N; Zerbib M; Benoît G; Droupy S; Molinié V; Vieillefond A; Tan PH; Richard S; Teh BT
BMC Cancer; 2010 May; 10():196. PubMed ID: 20462447
[TBL] [Abstract][Full Text] [Related]
31. FOXI1 expression in chromophobe renal cell carcinoma and renal oncocytoma: a study of The Cancer Genome Atlas transcriptome-based outlier mining and immunohistochemistry.
Tong K; Hu Z
Virchows Arch; 2021 Apr; 478(4):647-658. PubMed ID: 32812119
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical expression of tumor antigens MAGE-A3/4 and NY-ESO-1 in renal oncocytoma and chromophobe renal cell carcinoma.
Demirović A; Džombeta T; Tomas D; Spajić B; Pavić I; Hudolin T; Milošević M; Cupić H; Krušlin B
Pathol Res Pract; 2010 Oct; 206(10):695-9. PubMed ID: 20591578
[TBL] [Abstract][Full Text] [Related]
33. p63 immunohistochemistry differentiates salivary gland oncocytoma and oncocytic carcinoma from metastatic renal cell carcinoma.
McHugh JB; Hoschar AP; Dvorakova M; Parwani AV; Barnes EL; Seethala RR
Head Neck Pathol; 2007 Dec; 1(2):123-31. PubMed ID: 20614263
[TBL] [Abstract][Full Text] [Related]
34. [Oncocytoma versus chromophobe renal cell carcinoma: Is there something in between?].
Lüders C; Kristiansen G
Pathologe; 2016 Mar; 37(2):153-8. PubMed ID: 26925847
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemistry for the differential diagnosis of renal tumors with oncocytic features.
Fernández-Aceñero MJ; Cazorla A; Manzarbeitia F
Urol Oncol; 2011; 29(5):545-9. PubMed ID: 19926310
[TBL] [Abstract][Full Text] [Related]
36. L1 Cell Adhesion Molecule (L1CAM) Expression and Molecular Alterations Distinguish Low-Grade Oncocytic Tumor From Eosinophilic Chromophobe Renal Cell Carcinoma.
Alghamdi M; Chen JF; Jungbluth A; Koutzaki S; Palmer MB; Al-Ahmadie HA; Fine SW; Gopalan A; Sarungbam J; Sirintrapun SJ; Tickoo SK; Reuter VE; Chen YB
Mod Pathol; 2024 May; 37(5):100467. PubMed ID: 38460672
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic accuracy for hybrid oncocytic/chromophobe renal cell tumors by exploiting an immunohistochemical and histochemical combined panel.
Roncati L; Barbolini G; Maiorana A
Diagnosis (Berl); 2017 Jun; 4(2):109-110. PubMed ID: 29536916
[No Abstract] [Full Text] [Related]
38. NKX6-1 Is a Less Sensitive But Specific Biomarker of Chromophobe Renal Cell Carcinoma.
Xie B; Tong K; Yang J; Wang T; Cheng L; Zeng S; Hu Z
Am J Surg Pathol; 2022 Jun; 46(6):809-815. PubMed ID: 35256556
[TBL] [Abstract][Full Text] [Related]
39. Expression of S-100 protein in renal cell neoplasms.
Lin F; Yang W; Betten M; Teh BT; Yang XJ;
Hum Pathol; 2006 Apr; 37(4):462-70. PubMed ID: 16564922
[TBL] [Abstract][Full Text] [Related]
40. Cytomorphology, immunoprofile, and management of renal oncocytic neoplasms.
Zhu B; Rohan SM; Lin X
Cancer Cytopathol; 2020 Dec; 128(12):962-970. PubMed ID: 32697415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]